Current Update on Nomenclature, Diagnosis, and Management of Metabolic Dysfunction–associated Steatotic Liver Disease: Radiologists’ Perspective
Erica Osta, Florentino Saenz Rios, Sriram Jaganathan, Courtney Thomas, Eugenia Tsai, Venkateswar R. Surabhi, Srinivasa R. Prasad, Venkata S. Katabathina
Abstract
Metabolic dysfunction–associated steatotic liver disease (MASLD) is the new name for nonalcoholic fatty liver disease and continues to be a significant global health care problem, commensurate with the increased prevalence of obesity and metabolic syndrome.
Topics & Concepts
MedicineSteatosisIntensive care medicineFatty liverClinical PracticeLiver diseaseConsensus conferenceDiseaseNatural historySteatohepatitisMetabolic syndromeLiver fibrosisMEDLINEDelphi methodChronic liver diseaseIntervention (counseling)Health carePathologyPerspective (graphical)Global healthPrecision medicineHepatic fibrosisObesityLiver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and LipoproteinsLiver Disease and Transplantation